BNA's Pharmaceutical Patent Law: A Prescription for Success in Challenging Times Conference
Bruce Wexler will be the keynote speaker at BNA's Pharmaceutical Patent Law: A Prescription for Success in Challenging Times seminar. This event will take place on November 12, 2008 at the Ritz-Carlton Arlington, VA.
The defense of inequitable conduct has been called a "plague" on the patent system, yet it continues to be asserted routinely in patent cases. Over the years, the rulings of the Court of Appeals for the Federal Circuit have both fostered the plague and attempted to quell it. Mr. Wexler who successfully tried this defense, offers insights into the current trends and issues surrounding this highly charged area of the law.
BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference. BNA offers a prescription for success as legislative, judicial, administrative, and 'marketplace' developments continue to advance at breakneck speed. This conference will help you:
Get maximum value from your patents.
Learn winning litigation tactics from leading practitioners.
Avoid antitrust consequences when settling cases.
Look for trends-- where does case law go from here?
Recent case law developments, the 2003 Medicare Modernization Act, and even the 2007 FDA Amendments Act have changed the landscape for drug companies that defend or challenge patents. As brand-name companies strive to maximize the market exclusivity for their products, generic makers try to enter the market before patents expire. Your clients will need advice on the nuts and bolts of managing product life cycles. How do they position their products for the best possible market share? This conference will address non-patent exclusivities and the possibility of using International Trade Commission procedures to protect drugs from inappropriate competition.
For more information or to register for this conference go to